DVY vs IBB
iShares Select Dividend ETF vs iShares Biotechnology ETF
- • DVY has the lower expense ratio at 0.38% vs 0.44% for IBB.
- • DVY pays a higher dividend yield (3.37%).
Side-by-side metrics
| Metric | DVY | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.38% | 0.44% |
Dividend yield Trailing 12-month yield. | 3.37% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $22.90B | $9.09B |
YTD return | 13.81% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.57 | 0.69 |
P/E ratio | 15.68 | 24.89 |
Last price | $158.11 | $197.34 |
Inception | — | — |
Issuer | iShares | iShares |
DVY top holdings
| MO | Altria Group Inc | 2.26% |
| TROW | T. Rowe Price Group Inc | 2.22% |
| PRU | Prudential Financial Inc | 2.01% |
| PFE | Pfizer Inc | 1.99% |
| OKE | ONEOK Inc | 1.71% |
| HPQ | HP Inc | 1.68% |
| KMB | Kimberly-Clark Corp | 1.68% |
| EIX | Edison International | 1.63% |
| VZ | Verizon Communications Inc | 1.62% |
| F | Ford Motor Co | 1.58% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About DVY
DVY (iShares Select Dividend ETF) is 100 high-dividend-yielding US stocks. Managed by iShares, the fund carries $22.9B in assets under management, an expense ratio of 0.38%, a dividend yield of 3.37%. Its largest holding is Altria Group Inc (MO), which represents 2.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 10.1%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.